Health
FDA Reports Two Deaths Tied to Bootleg Weight-Loss Drug
FDA adverse event reports link two deaths to bootleg retatrutide, an unapproved weight-loss drug, exposing a fast-growing black market.
—6 min read
Tag
4 articles
FDA adverse event reports link two deaths to bootleg retatrutide, an unapproved weight-loss drug, exposing a fast-growing black market.
The FDA is investigating two reported deaths tied to bootleg retatrutide, an unapproved weight-loss drug, as the black market for the peptide surges.
Demand for Eli Lilly's unapproved weight-loss drug retatrutide has spawned a thriving black market. At least 14 hospitalizations linked to its use.
Eli Lilly's retatrutide led to 28.3% weight loss in a Phase 3 trial, approaching bariatric surgery results. But high side effect rates raise questions.